Loading…
← CockpitCompetitor Analysis › QC7.SI Q & M Dental Group (Singapore) LimitedOpen in the cockpit ↗

Q & M Dental Group (Singapore) LimitedQC7.SICompetitor analysis, valuation and peers

Singapore · SGD·Health Care›Hospital/Nursing Management
Momentum weak 22
Mkt cap
$326M
US dollars, full cap
Free float
37%
of shares outstanding
$/day
$115,740
20-day average traded
Fwd P/E
31.6×
forward earnings
ROIC−WACC
+1.4 pp
WACC 5.3%
Hurdle
+0 pp
Req g minus delivered
Next earnings
103 days
1 Mar 2027
Close · SGDS$0.45
1D-2.2%
1W-8.2%
1M-16.0%
3M-19.8%
6M-25.8%
YTD-19.1%
1Y-13.6%
ATR %2.9%
52w lowhigh29.9% off high

What Q & M Dental Group (Singapore) does

No business profile yet.

Q & M Dental Group (Singapore) at a glance

Size Q & M Dental Group (Singapore) (QC7.SI) is a Singapore Health Care company (Hospital/Nursing Management) with a market value of $326M, the 133rd largest of 184 Singapore companies the cockpit tracks. Shares closed at S$0.45 on 18 Nov 2026.

Performance Over six months the shares fell 25.8%, against -3.4% for the median peer and -4.6% for the Singapore market (cap-weighted) — 3rd lowest of 19 in its peer set.

Growth Revenue grew 15.8% over the last twelve months (peer median +10.9%); the operating margin is 9.0% (peer median 10.7%).

Valuation It trades at 31.6× forward earnings against a peer median of 20.5× (5th most expensive of 14).

Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +0 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 1.4 points above its cost of capital (5.3% WACC).

Next results Next results expected around 1 Mar 2027 (exchange calendar; dates can move).

Relative performance

809010011021 May 202621 Aug 202618 Nov 2026Peer median 95QC7.SI 75
Six months, rebased to 100: Q & M Dental Group (Singapore) against the median of its 20 peers (local-currency closes).

Q & M Dental Group (Singapore) financials

Reported figures in SGD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueS$208MS$197MS$181MS$183MS$181M
Revenue growth—+9%-1%+1%—
Gross profitS$34.8MS$38.6MS$37.8MS$36.6MS$35.4M
EBITDAS$40.1MS$42.3MS$41.5MS$39.7MS$36.0M
Net incomeS$10.4MS$9.31MS$14.3MS$11.5MS$11.3M
Free cash flowS$17.9MS$27.8MS$28.4MS$23.6MS$22.2M
Capital expenditureS$11.8MS$4.97MS$8.11MS$6.55MS$11.0M
Total debtn/aS$188MS$115MS$130MS$141M

Quarterly statements and history in the cockpit →

Q & M Dental Group (Singapore) competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%VMD301103INDRAMEDCO26093012391515VOX6062GHCARTEMISMEDKOVAIHCGGDSJLHLRHKPARKHOSPSQC7.SI6-month return →1-month return →
Up and to the right = strong over both horizons. Q & M Dental Group (Singapore) is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×VMDINDRAMEDCO3012391515VOX6062GHCARTEMISMEDHCGCBAVJLHLPARKHOSPSQC7.SIRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Q & M Dental Group (Singapore) is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%VMD301103KMCSHILINDRAMEDCO26093012391515VOXGHCARTEMISMEDKOVAIA50GDSCBAVPARKHOSPSQC7.SIGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Q & M Dental Group (Singapore) is the large dot.

Q & M Dental Group (Singapore) competitors and peer comparison

How Q & M Dental Group (Singapore) compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Q & M Dental Group (Singapore) against its 20 peers (data as of 18 Nov 2026)
MeasureQC7.SIPeer medianRank in peer set
1-month return-16.0%+2.1%lowest of 20
6-month return-25.8%-3.4%3rd lowest of 19
Distance from 52-week high-29.9%-18.4%9th lowest of 21
Revenue growth (TTM)+15.8%+10.9%7th highest of 21
Operating margin9.0%10.7%9th lowest of 21
Forward P/E31.6×20.5×5th most expensive of 14
Growth the price implies (Req g, 7 yrs)7.7%6.5%8th most demanding of 17
Growth delivered (Del g)+7.5%+16.0%3rd lowest of 17
Hurdle (Req g minus delivered)+0.2 pp-7.1 pp5th most demanding of 17
ROIC minus cost of capital+1.4 pp+0.6 pp10th highest of 21
EV / EBITDA12.9×14.6×9th cheapest of 18
Net debt / EBITDA1.6×0.3×6th most indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are Q & M Dental Group (Singapore)'s closest peers?
The cockpit's peer set: Viemed Healthcare (VMD), Liaoning He Eye Hospital (301103.SZ), KMC Speciality Hospitals (India) (KMCSHIL.NS), Indraprastha Medical (INDRAMEDCO.NS), Bayzed Health (2609.HK), Bright Eye Hospital (301239.SZ), China Resources Medical (1515.HK), Voxel (VOX.WA).
Is Q & M Dental Group (Singapore) expensive compared with its peers?
On forward p/e it trades at 31.6× against a peer median of 20.5×, 5th most expensive of 14 in its peer set. For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +0 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Q & M Dental Group (Singapore) stock performed?
Over six months to 18 Nov 2026 the shares returned -25.8% against -3.4% for the median peer; over one year -13.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.